Johnson & Johnson Total Assets 2006-2020 | JNJ

Johnson & Johnson total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Johnson & Johnson total assets for the quarter ending June 30, 2020 were $158.380B, a 2.1% increase year-over-year.
  • Johnson & Johnson total assets for 2019 were $157.728B, a 3.12% increase from 2018.
  • Johnson & Johnson total assets for 2018 were $152.954B, a 2.76% decline from 2017.
  • Johnson & Johnson total assets for 2017 were $157.303B, a 11.4% increase from 2016.
Johnson & Johnson Annual Total Assets
(Millions of US $)
2019 $157,728
2018 $152,954
2017 $157,303
2016 $141,208
2015 $133,411
2014 $130,358
2013 $132,683
2012 $121,347
2011 $113,644
2010 $102,908
2009 $94,682
2008 $84,912
2007 $80,954
2006 $70,556
2005 $58,864
Johnson & Johnson Quarterly Total Assets
(Millions of US $)
2020-06-30 $158,380
2020-03-31 $155,017
2019-12-31 $157,728
2019-09-30 $155,521
2019-06-30 $155,117
2019-03-31 $150,027
2018-12-31 $152,954
2018-09-30 $155,703
2018-06-30 $155,365
2018-03-31 $156,625
2017-12-31 $157,303
2017-09-30 $155,658
2017-06-30 $152,807
2017-03-31 $144,918
2016-12-31 $141,208
2016-09-30 $140,369
2016-06-30 $139,814
2016-03-31 $136,231
2015-12-31 $133,411
2015-09-30 $133,266
2015-06-30 $132,036
2015-03-31 $128,590
2014-12-31 $130,358
2014-09-30 $132,097
2014-06-30 $135,200
2014-03-31 $133,330
2013-12-31 $132,683
2013-09-30 $126,933
2013-06-30 $124,325
2013-03-31 $121,536
2012-12-31 $121,347
2012-09-30 $118,951
2012-06-30 $115,750
2012-03-31 $116,194
2011-12-31 $113,644
2011-09-30 $111,821
2011-06-30 $112,114
2011-03-31 $108,150
2010-12-31 $102,908
2010-09-30 $98,247
2010-06-30 $92,300
2010-03-31 $93,441
2009-12-31 $94,682
2009-09-30 $91,558
2009-06-30 $87,438
2009-03-31 $86,100
2008-12-31 $84,912
2008-09-30 $87,724
2008-06-30 $88,113
2008-03-31 $85,995
2007-12-31 $80,954
2007-09-30 $78,665
2007-06-30 $74,683
2007-03-31 $73,066
2006-12-31 $70,556
2006-09-30 $61,238
2006-06-30 $60,990
2006-03-31 $62,133
2005-12-31 $58,864
2005-09-30 $56,574
2005-06-30 $54,553
2005-03-31 $54,446
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $391.238B $82.059B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $294.553B 0.00
Pfizer (PFE) United States $213.662B 13.35
Merck (MRK) United States $204.919B 14.63
Novartis AG (NVS) Switzerland $189.756B 14.75
AbbVie (ABBV) United States $163.988B 9.99
Novo Nordisk (NVO) Denmark $152.214B 24.77
Eli Lilly (LLY) United States $146.273B 22.33
AstraZeneca (AZN) United Kingdom $145.417B 28.27
Sanofi (SNY) $128.988B 15.33
GlaxoSmithKline (GSK) United Kingdom $102.323B 13.42
Bayer (BAYRY) Germany $61.403B 8.85
H Lundbeck (HLUYY) Denmark $7.388B 0.00
Innoviva (INVA) United States $1.370B 6.56